China National Center for Cardiovascular Diseases: Myocardial Infarction trials

The registry lists 11 Myocardial Infarction studies with China National Center for Cardiovascular Diseases as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 4 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• TOP-CABG Trial: Follow-up Extension (TOP-CABG FE)Not yet recruitingNCT07871591
• A Privacy-Preserving OCR-LLM System for Coronary Syndrome Subtyping From Admission HPI: Multicenter Validation in China and the USNot yet recruitingNCT07449429
• Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent RestenosisNot yet recruitingNCT06981845Not applicable
• Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in ChinaRecruitingNCT04088682
• Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass GraftingCompletedNCT05380063Phase 4
• China Tongxinluo Study for Myocardial Protection in Patients With Acute Myocardial InfarctionStatus unknownNCT03792035Phase 4
• Hs-cTnI Diagnosis of NSTE-ACS Patients in ChinaStatus unknownNCT03734796
• Optical Coherence Tomography Examination in Acute Myocardial InfarctionStatus unknownNCT03593928
• COmprehensive Remote Ischemic Conditioning in Myocardial InfarctionStatus unknownNCT03233919Not applicable
• China PEACE II: Quality Improvement for Acute Myocardial InfarctionCompletedNCT02322944Not applicable
• Stem Cell Therapy to Improve Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting (CABG)Status unknownNCT00395811Phase 1/2